Dr. Marc Lang
Medicinal Chemistry
PIQUR
Switzerland
Biography
Head Medicinal Chemistry, has more than 30 years of experience in medicinal chemistry, of which some 20 years in Oncology and Immunology. He has contributed to three multi-billion Novartis compounds on market (Femara®, Reyataz® and Tasigna®), and five promising compounds in clinical trials. Until October 2012, he was Head of Medicinal Chemistry for Oncology research programs at Novartis Pharma AG.
Research Interest
Oncology and Immunology
